Clinical Trials List
Protocol NumberCR9108914
Not yet recruiting
2007-07-01 - 2009-02-28
Phase II
Terminated2
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
219 participants
